ESC 365 - Therapeutic implications: can we target adipose tissue to treat HFpEF

ESC2025 Premium Access

Therapeutic implications: can we target adipose tissue to treat HFpEF

Session: The adipokine hypothesis and a new era in HFpEF science

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Speaker: Doctor N. Pagidipati (Durham, US)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Neha Pagidipati

Duke Clinical Research Institute, Durham (United States of America)

3 presentations

1 follower

3 more presentations in this session

The adipokine hypothesis of HFpEF: a paradigm shift in understanding

Speaker: Professor M. Packer (Dallas, US)

Clinical and mechanistic evidence linking obesity to HFpEF

Speaker: Professor G. Schiattarella (Berlin, DE)

The adipokine hypothesis and a new era in HFpEF science: does the adipokine hypothesis hold up? - discussion

Access the full session

The adipokine hypothesis and a new era in HFpEF science

Speakers: Doctor N. Pagidipati, Professor M. Packer, Professor G. Schiattarella

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources